EULAV Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.38M | Buy |
31,000
+21,000
| +210% | +$6.36M | 0.22% | 102 |
|
|
2025
Q1 | $3.31M | Hold |
10,000
| – | – | 0.08% | 147 |
|
|
2024
Q4 | $3.09M | Hold |
10,000
| – | – | 0.07% | 149 |
|
|
2024
Q3 | $2.12M | Hold |
10,000
| – | – | 0.05% | 158 |
|
|
2024
Q2 | $2.8M | Sell |
10,000
-1,000
| -9% | -$280K | 0.08% | 152 |
|
|
2024
Q1 | $2.94M | Sell |
11,000
-2,000
| -15% | -$534K | 0.08% | 154 |
|
|
2023
Q4 | $3.01M | Buy |
+13,000
| New | +$3.01M | 0.09% | 150 |
|